NCT01100788

Brief Summary

Populations that report high fiber consumption demonstrate lower rates of obesity. Enhanced satiety may play a key role in this relationship. The colonic fermentation of fibers is theorized to influence satiety and food intake. Short chain fructooligosaccharide (scFOS) are rapidly fermentable fibers that can easily be added to foods to impact these parameters. The objective of this study was to evaluate the satiety response of scFOS and its ability to decrease food intake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for early_phase_1 healthy

Timeline
Completed

Started Mar 2009

Shorter than P25 for early_phase_1 healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2010

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 9, 2010

Completed
Last Updated

April 9, 2010

Status Verified

April 1, 2010

Enrollment Period

3 months

First QC Date

March 5, 2010

Last Update Submit

April 8, 2010

Conditions

Outcome Measures

Primary Outcomes (1)

  • Satiety response using visual analogue scales

    Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).

    0, 15, 30, 45, 60, 90, 120, 180, 240 minutes postprandially

Secondary Outcomes (3)

  • Ad libitum food intake

    240 minutes postprandially and over 24 hours

  • Breath hydrogen response

    0, 240 minutes

  • Gastrointestinal tolerance using visual analogue scales (VAS)

    24 hours

Study Arms (3)

Placebo

PLACEBO COMPARATOR

No treatment

Other: Placebo

scFOS 5 g

EXPERIMENTAL

5 g scFOS

Dietary Supplement: Short chain fructo-oligosaccharide (scFOS) 5 g

scFOS 8 g

EXPERIMENTAL

8 g scFOS

Dietary Supplement: Short chain fructooligosaccharide (scFOS) 8 g

Interventions

Dietary Supplement: scFOS 5 g Novel fiber administered in two 5 g doses--the first in a beverage and the second in a solid chew.

Also known as: fructo-oligosaccharide
scFOS 5 g
PlaceboOTHER

Treatment without scFOS fiber

Placebo

Novel fiber administered in two 8 g doses--the first in a beverage and the second in a solid chew.

scFOS 8 g

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men and women
  • Age 18-64 years
  • Non-smoking
  • Not taking medication
  • Non-dieting (weight stable in prior 3 months)
  • BMI 18-27
  • English literacy

You may not qualify if:

  • Do not regularly consume breakfast
  • Food allergies to ingredients found in study products
  • BMI \<18 or \>27
  • Diagnosed cardiovascular, renal, or hepatic disease diabetes mellitus
  • Cancer in previous 5 years (except basal cell carcinoma of the skin)
  • Any gastrointestinal disease or condition
  • Recent bacterial infection (\< 3 months)
  • Recent or concurrent participation in an intervention research study
  • History of drug or alcohol abuse in prior 6 months
  • Use of lipid-lowering, anti-hypertensive, or anti-inflammatory steroid medication
  • Eating disorder
  • Vegetarians
  • People who eat more than approximately 15 grams of fiber per day
  • Women who are pregnant or lactating
  • Women with irregular menstrual cycles

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Saint Paul, Minnesota, 55108, United States

Location

MeSH Terms

Interventions

fructo-oligosaccharide-shitake

Study Officials

  • Joanne Slavin

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 5, 2010

First Posted

April 9, 2010

Study Start

March 1, 2009

Primary Completion

June 1, 2009

Study Completion

June 1, 2009

Last Updated

April 9, 2010

Record last verified: 2010-04

Locations